Quick Answer
INTERPACE BIOSCIENCES, INC. reported Revenue (ASC 606) of $38.73 million for fiscal year 2025.
INTERPACE BIOSCIENCES, INC. Revenue (ASC 606) — Annual History
| Fiscal Year | Revenue (ASC 606) | YoY Change |
|---|---|---|
| 2025 | $38.73M | -17.5% |
| 2024 | $46.93M | +17.2% |
| 2023 | $40.04M | +25.7% |
| 2022 | $31.84M | -3.9% |
| 2021 | $33.12M | +2.2% |
| 2020 | $32.40M | +33.8% |
| 2019 | $24.22M | +10.6% |
| 2018 | $21.90M | +37.7% |
| 2017 | $15.90M | — |
Quarterly Revenue (ASC 606)
| Quarter Ending | Revenue (ASC 606) | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.76M | -28.8% | -5.2% |
| June 30, 2025 | $9.23M | -23.3% | -19.8% |
| March 31, 2025 | $11.52M | +13.1% | -6.3% |
| September 30, 2024 | $12.29M | +35.4% | +2.1% |
| June 30, 2024 | $12.04M | +9.2% | +18.3% |
| March 31, 2024 | $10.18M | +3.6% | +12.1% |
| September 30, 2023 | $9.08M | +10.9% | -17.7% |
| June 30, 2023 | $11.03M | +49.1% | +12.2% |
- INTERPACE BIOSCIENCES, INC. showed a decrease of -17.5% in Revenue (ASC 606) compared to the prior fiscal year.
- Over the 2017–2025 period, INTERPACE BIOSCIENCES, INC.’s revenue (asc 606) has grown by 143.6% (from $15.90 million to $38.73 million).
- The most recent figure is from INTERPACE BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: